Recursion Hits 52-Week Low
Recursion Pharmaceuticals reaches new 52-week low, potentially presenting a buying opportunity. The company was previously held by Nvidia.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.